期刊文献+

Quantitative and qualitative changes in serum luteinizing hormone after injectable testosterone undecanoate treatment in hypogonadal men

Quantitative and qualitative changes in serum luteinizing hormone after injectable testosterone undecanoate treatment in hypogonadal men
下载PDF
导出
摘要 Aim: To clarify the immuno-active LH (i-LH) and bioactive LH (b-LH) responses and qualitative changes in the cir-culating LH to testosterone undecanoate (TU) injection. Methods: Eight men with Klinefelter's syndrome were re-cruited for the study. They received crossover injections of TU at doses of 500 and 1000 mg. Serum i-LH and b-LHlevels before and at various time intervals after TU injection were measured and the serum i-LH, b-LH, b-LH/i-LH(B/I) and testosterone/sex hormone-binding globulin (T/SHBG) ratio in LH-responders and LH non-responders werecompared. Results: A parallel suppression of serum i-LH and b-LH was consistent with their overall high correlationbetween each other ( r = 0.84, P < 0. 001). Mean serum i-FSH levels were decreased by TU injection at both doseswithout dose-response effects. LH-responders had lower baseline serum i-LH and b-LH, and higher E_2 levels and T/SHBG ratio. There was a quantitative change in serum LH as induced by TU without qualitative change within LH-re-sponders os LH-non-responders. Conclusion: A high loading dose (1000 mg) of TU is important for the initial sup-pression of LH. With the lower dose (500 mg), repeated injections will be required to attain such LH suppression forthe purpose of fertility regulation. The lower baseline serum i-LH level may be an intrinsic characteristic of LH-respon-ders. Aim: To clarify the immuno-active LH (i-LH) and bioactive LH (b-LH) responses and qualitative changes in the cir-culating LH to testosterone undecanoate (TU) injection. Methods: Eight men with Klinefelter's syndrome were re-cruited for the study. They received crossover injections of TU at doses of 500 and 1000 mg. Serum i-LH and b-LHlevels before and at various time intervals after TU injection were measured and the serum i-LH, b-LH, b-LH/i-LH(B/I) and testosterone/sex hormone-binding globulin (T/SHBG) ratio in LH-responders and LH non-responders werecompared. Results: A parallel suppression of serum i-LH and b-LH was consistent with their overall high correlationbetween each other ( r = 0.84, P < 0. 001). Mean serum i-FSH levels were decreased by TU injection at both doseswithout dose-response effects. LH-responders had lower baseline serum i-LH and b-LH, and higher E_2 levels and T/SHBG ratio. There was a quantitative change in serum LH as induced by TU without qualitative change within LH-re-sponders os LH-non-responders. Conclusion: A high loading dose (1000 mg) of TU is important for the initial sup-pression of LH. With the lower dose (500 mg), repeated injections will be required to attain such LH suppression forthe purpose of fertility regulation. The lower baseline serum i-LH level may be an intrinsic characteristic of LH-respon-ders.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2000年第1期65-71,共7页 亚洲男性学杂志(英文版)
关键词 LH bioactivity TESTOSTERONE ESTROGEN LH bioactivity testosterone estrogen
  • 相关文献

参考文献10

  • 1Beitins IZ,Axelrod L,Ostrea T,Little R,Badger TM.Hypogonadism in a male with an immunologically active, biologically inactive luteinizing hormone: Characterization of the abnormal hormone[].Journal of Clinical Endocrinology Metabolism The.
  • 2Matsumoto AM,Paulsen CA,Bremner WJ.Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men[].The Journal of Clinical Endocrinology.1984
  • 3van Damme MP,Robertson DM,Diczfalusy E.An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations[].Acta Endocrinol (Copenhagen).1974
  • 4McLachlan RI,Wreford NG,de Kretser DM,Robertson DM.The effect of recombinant follicle-stimulating hormone on the restoration of spermatogenesis in the gonadotropinreleasing hormone-immunized adult rat[].The Journal of Endocrinology.1995
  • 5Zhang GY,Gu YQ,Wang XH,Cui YG,Bremner WJ.A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men[].Journal of Andrology.1998
  • 6Bremner WJ,Matsumoto AM,Sussman AM,Paulsen CA.Follicle-stimulating hormone and human spermatogenesis[].The Journal of Clinical Investigation.1981
  • 7Carani C,Celani MF,Zini D,Baldini A,Della Casa L,Marrama P.Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate[].Acta Endocrinol (Copenhagen).1989
  • 8Dufau ML,Hodgen GD,Goodman AL,Catt KJ.Bioassay of circulating luteinizing hormone in the rhesus monkey; comparison with radioimmunoassay during physiological changes[].The Journal of Endocrinology.1977
  • 9Partsch CJ,Weinbauer GF,Fang RY,Nieschlag E.Injectable testosterone undecanoate has more favourable pharmacokinetics and pharmacodynamics than testosterone enanthate[].European Journal of Endocrinology.1995
  • 10Handelsnmn DJ,Conway AJ,Boylan LM.Pharmacokinetics and pharmacodynamics of testosterone pellets in man[].The Journal of Clinical Endocrinology.1990

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部